Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
This study has been completed.
First Posted: September 17, 2013
Last Update Posted: March 26, 2015
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2015|
|Primary Completion Date:||September 2014 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||January 16, 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Lok AS, Pan CQ, Han SH, Trinh HN, Fessel WJ, Rodell T, Massetto B, Lin L, Gaggar A, Subramanian GM, McHutchison JG, Ferrari C, Lee H, Gordon SC, Gane EJ. Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B. J Hepatol. 2016 Sep;65(3):509-16. doi: 10.1016/j.jhep.2016.05.016. Epub 2016 May 19.